Ocuphire Pharma (OCUP) Insider Trading & Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free OCUP Stock Alerts $1.83 -0.11 (-5.67%) (As of 04:00 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ocuphire Pharma (NASDAQ:OCUP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$74,100.00Number OfInsiders Selling(Last 12 Months)0 Get OCUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocuphire Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUP Insider Buying and Selling by Quarter Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Ocuphire Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2024Joseph K SchachleCOOBuy2,000$2.05$4,100.00 3/21/2024Nirav S JhaveriCFOBuy10,000$2.10$21,000.00 3/18/2024George MagrathCEOBuy25,000$1.96$49,000.00 (Data available from 1/1/2013 forward) OCUP Insider Trading Activity - Frequently Asked Questions Who is on Ocuphire Pharma's Insider Roster? The list of insiders at Ocuphire Pharma includes George Magrath, James S J Manuso, Jay Pepose, Joseph K Schachle, Mina Sooch, and Nirav S Jhaveri. Learn more on insiders at OCUP. What percentage of Ocuphire Pharma stock is owned by insiders? 8.70% of Ocuphire Pharma stock is owned by insiders. Learn more on OCUP's insider holdings. Which Ocuphire Pharma insiders have been buying company stock? The following insiders have purchased OCUP shares in the last 24 months: George Magrath ($49,000.00), James S J Manuso ($9,950.00), Joseph K Schachle ($4,100.00), Mina Sooch ($25,875.00), and Nirav S Jhaveri ($21,000.00). How much insider buying is happening at Ocuphire Pharma? Insiders have purchased a total of 54,500 OCUP shares in the last 24 months for a total of $109,925.00 bought. More Insider Trading Tools from MarketBeat Related Companies: Clene Insider Selling HCW Biologics Insider Selling Aadi Bioscience Insider Selling Gain Therapeutics Insider Selling Xilio Therapeutics Insider Selling Immuneering Insider Selling Nabriva Therapeutics Insider Selling Sensei Biotherapeutics Insider Selling Lexaria Bioscience Insider Selling Unicycive Therapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:OCUP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
